Walpar Nutritions Ltd

Walpar Nutrition Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Walpar Nutritions Ltd

₹ 50.0 3.20%
24 Dec - close price
walparnutritions.com NSE - SME: WALPAR
About

Incorporated in 2009, Walpar Nutritions Ltd manufactures and trades Pharmaceutical, Nutraceutical, Herbal and Ayurvedic commodities[1]

Key Points

Business Overview:[1]
Company manufactures and sells Nutraceutical and Herbal dietary supplement formulations, ingredients and research. It manufactures private label brands for different companies and its own brands, selling through online and direct channels. Company is a specialized Contract manufacturer for different formulation in Nutraceuticals and Herbal products

Website NSE - SM
  • Market Cap ₹ 47.0 Cr.
  • Current Price ₹ 50.0
  • High / Low ₹ 77.0 / 39.0
  • Stock P/E 23.8
  • Book Value ₹ 15.4
  • Dividend Yield 0.00 %
  • ROCE 11.6 %
  • ROE 8.60 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Debtor days have improved from 103 to 71.8 days.
  • Company's working capital requirements have reduced from 91.3 days to 48.6 days

Cons

  • Stock is trading at 3.25 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.79%
  • Company has a low return on equity of 5.67% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
13.98 12.78 13.74 14.97 25.49 25.83 24.92
13.44 12.26 13.92 14.01 24.96 24.60 23.35
Operating Profit 0.54 0.52 -0.18 0.96 0.53 1.23 1.57
OPM % 3.86% 4.07% -1.31% 6.41% 2.08% 4.76% 6.30%
0.04 0.00 0.03 0.24 0.02 0.11 0.03
Interest 0.24 0.24 0.17 0.17 0.10 0.10 0.05
Depreciation 0.13 0.15 0.12 0.13 0.10 0.11 0.18
Profit before tax 0.21 0.13 -0.44 0.90 0.35 1.13 1.37
Tax % 23.81% -100.00% 9.09% 13.33% 22.86% 24.78% 19.71%
0.15 0.27 -0.48 0.78 0.27 0.85 1.12
EPS in Rs 0.16 0.30 -0.53 0.86 0.29 0.90 1.19
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 1m Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1.43 6.07 26.76 28.70 51.31 50.75
1.05 5.61 25.68 27.92 49.54 47.95
Operating Profit 0.38 0.46 1.08 0.78 1.77 2.80
OPM % 26.57% 7.58% 4.04% 2.72% 3.45% 5.52%
0.00 0.00 0.02 0.27 0.13 0.14
Interest 0.05 0.18 0.48 0.34 0.21 0.15
Depreciation 0.02 0.12 0.28 0.25 0.21 0.29
Profit before tax 0.31 0.16 0.34 0.46 1.48 2.50
Tax % 25.81% 6.25% -26.47% 34.78% 24.32%
0.23 0.15 0.42 0.29 1.11 1.97
EPS in Rs 0.38 0.22 0.46 0.32 1.18 2.09
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 104%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 92%
TTM: 88%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 52%
1 Year: 14%
Return on Equity
10 Years: %
5 Years: %
3 Years: 6%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3.00 3.34 4.54 4.54 4.70 9.39
Reserves 0.23 1.44 6.49 6.78 8.64 5.06
5.88 5.46 4.38 3.21 0.32 1.07
5.44 5.45 7.95 7.33 9.84 14.87
Total Liabilities 14.55 15.69 23.36 21.86 23.50 30.39
1.15 1.07 0.94 0.83 1.48 1.83
CWIP 0.00 0.00 0.00 0.02 0.02 0.02
Investments 0.00 0.06 2.93 2.84 4.70 4.70
13.40 14.56 19.49 18.17 17.30 23.84
Total Assets 14.55 15.69 23.36 21.86 23.50 30.39

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.40 1.38 -0.32 1.09 3.13
0.00 -0.70 -4.58 0.46 -0.88
-0.24 -0.06 4.27 -1.52 -2.18
Net Cash Flow 0.17 0.62 -0.63 0.03 0.07

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 2,141.50 430.54 124.26 111.66 71.78
Inventory Days 1,690.75 369.26 103.22 89.87 39.99
Days Payable 2,156.44 434.08 130.02 99.69 67.10
Cash Conversion Cycle 1,675.81 365.73 97.45 101.84 44.67
Working Capital Days 1,556.99 439.56 117.71 107.72 48.59
ROCE % 6.55% 5.34% 11.56%

Shareholding Pattern

Numbers in percentages

Sep 2021Mar 2022Sep 2022Mar 2023May 2023Sep 2023Mar 2024Sep 2024
71.02% 71.02% 70.58% 70.54% 71.46% 71.46% 71.23% 68.44%
28.98% 28.98% 29.42% 29.46% 28.54% 28.54% 28.77% 31.56%
No. of Shareholders 496460291270258233226335

Documents

Announcements

Annual reports